At the news
? NEUTRALIMPACT 3/10 144 filed Jun 26, 2026 at 17:04 ET
Atlas Venture Opportunity Fund I, L.P., a major early investor, filed a Form 144 notice of intent to sell 64,411 shares of Dyne Therapeutics common stock, valued at approximately $1.33M at the filing date. This represents a routine insider sale by a pre-IPO venture backer and does not signal a change in company outlook.
- Atlas Venture Opportunity Fund I, L.P. filed Form 144 to sell 64,411 shares of Dyne Therapeutics common stock.
- The estimated market value of the proposed sale is approximately $1.33 million.
- The shares were acquired in a private placement on August 7, 2020.
- The insider has sold no other securities in the past 3 months.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access